|
Platform development for target identification in high risk pediatric leukemias |
Columbia University, St. Jude Children’s Research Hospital |
The Brian Morden Foundation |
|
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida |
Tap Cancer Out, Layla’s Legacy Foundation |
|
Harmonizing Data Sharing Efforts towards a Federated Data Model |
University of California at Santa Cruz |
Pediatric Cancer Research Foundation |
|
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute |
Sammy’s Superheroes Foundation |
|
Overcoming Obstacles to Drug Development in Pediatric Cancer |
Stanford University School of Medicine |
Northwestern Mutual Foundation |
|
Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer |
The Regents of the University of California, Irvine |
The George Family Foundation |
|
Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow |
University of Colorado Denver |
Northwestern Mutual Foundation |
|
Multivalent Nanomedicine to Treat High-Risk Pediatric Solid Tumors |
Children’s Hospital of Philadelphia |
Flashes of Hope |
|
A comprehensive public resource for fusion-negative sarcoma sequencing data |
University of California San Francisco |
Northwestern Mutual Foundation |
|
Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion |
Research Institute at Nationwide Children's Hospital |
Cure4Cam Childhood Cancer Foundation |
